检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:祁志荣[1] 李明远[1] 张林[2] 蒋忠华[1] 代吕霞[1] 李虹[1]
机构地区:[1]四川大学华西基础医学与法医学院,四川成都610041 [2]四川大学华西医院生物治疗国家重点实验室,四川成都610041
出 处:《华西药学杂志》2006年第3期215-218,共4页West China Journal of Pharmaceutical Sciences
基 金:国家自然科学基金(30470613);教育部博士点专项基金(20040610053)
摘 要:目的构建大鼠干扰素诱导蛋白-10(IP-10)基因的真核表达质粒,并研究其在NIH 3T3细胞中的表达情况。方法通过PCR获得实验所需的IP-10基因片段,通过酶切IP-10基因片段、真核表达质粒载体pEGFP-c1和连接反应,构建IP-10的真核表达质粒pEGFP-c1-IP-10,重组质粒经限制性内切酶、PCR及DNA序列测定证实构建成功后,用PolyFect脂质体转染NIH 3T3细胞,然后用免疫荧光技术检测pEGFP-c1-IP-10在NIH 3T3细胞中的表达。结果酶切分析、PCR及DNA序列测定证实,IP-10基因片段被成功克隆入真核表达质粒载体pEGFP-c1,免疫荧光技术检测证实,该基因能在NIH 3T3细胞中表达。结论证实IP-10基因可在NIH 3T3细胞中表达,为将其作为DNA疫苗治疗自身免疫性疾病的研究奠定了基础。OBJECTIVE To construct a new recombinant eukaryotic expression plasmid by fusing rattus IFN - γ- inducible protein - 10 gene, and explore the expression of IP - 10 in NIH 3T3 cells. METHODS IP - 10 was cloned through polymerase chain reaction(PCR), then inserted into the eukaryotic expression vector pEGFP - cl. When the eukaryotic recombinant plasmid pEGFP - cl - IP - 10 was identified by PCR,restriction endonuclease digestion and sequence analysis, and then it was transfected into NIH3T3 cells by liposome protocol. Immunofluorescence photograph of fluorescence immunocytochemical method confirmed that the fusion gene can be expressed in the NIH3T3 cells. RESULTS PCR,restriction endonuclease digestion and sequence analysis revealed the IP- 10 gene was cloned into the eukaryotic expression plasmid vector pEGFP - cl successfully. Immunoflorescence photograph of fluoroscence immunocytochemical method confirmed that the gene can be expressed in NIH 3T3 cells. CONCLUSION The results confirmed that pEGFP - cl - IP - 10 fusion gene can be expressed in NIH 3T3 cell,which provides the basis as a DNA vaccine for studying the therapy of autoimmune disease(AID).
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3